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Organophosphorus (OP) pesticides are phos-
phate esters comprising a central phosphate
atom and three organic side chains, two of
which are usually ethyl or methyl and one of
which is more specific for a given pesticide.
Most OP pesticides registered for use in the
United States are used as insecticides. In
1999, 60 million pounds of OP pesticides
were used in agriculture and about 17 million
pounds were used in nonagricultural applica-
tions [U.S. Environmental Protection Agency
(U.S. EPA) 2003a, 2003b].
Chlorpyrifos (Figure 1), the most widely
used OP insecticide (U.S. EPA 2003a,
2003b), is used to control cutworms, root-
worms, termites, and other pests (Kamrin
1997). It is registered for use on a variety of
food crops, including grain, cotton, field,
fruit, nut, and vegetable crops. Until late
2000, chlorpyrifos was also a commonly used
residential pesticide for ﬁre ants, cockroaches,
and other household pests. In December
2000 all residential uses of chlorpyrifos,
except for preconstruction termite applica-
tions, were canceled, and its production for
these uses was stopped (U.S. EPA 2002). In
February 2001 residential formulation pro-
duction was stopped, and in December of
the same year, all retail sales for residential
applications were terminated.
Malathion (Figure 1) is one of the few OP
insecticides that still retains residential-use reg-
istrations (U.S. EPA 2003a). Malathion is
used to control sucking and chewing insects
on fruits and vegetables, mosquitoes, other
household pests, and animal parasites (Kamrin
1997). It has been used extensively in public
health applications in the United States to
control the spread of mosquito-borne diseases
such as West Nile disease.
We present an overview of the current
biomonitoring and other relevant data avail-
able on exposure to chlorpyrifos and
malathion and the use of these data in various
environmental public health applications.
Chlorpyrifos and malathion were chosen as
case-study examples because they have short
residence times in the body and are converted
to multiple metabolites in vivo that are
excreted in the urine. In addition, chlorpyri-
fos and malathion provide clear examples of
the complexities involved with interpreting
biomonitoring data, even though the litera-
ture base of these chemicals is relatively rich.
Pharmacokinetics
Most OP pesticides are believed to undergo a
similar metabolism (Barr et al. 2004;
Karalliedde et al. 2001; Wessels et al. 2003)
(Figure 2). Once they have entered the body,
OP insecticides are rapidly metabolized,
although a portion may be distributed to and
stored in adipose tissue (Kamrin 1997). OP
pesticides can be enzymatically converted to
their oxon form, which then reacts with avail-
able cholinesterase. The oxon also can be
enzymatically or spontaneously hydrolyzed to
form a dialkyl phosphate (DAP) metabolite
and an organic metabolite with the structure
of the leaving group. For example, chlorpyri-
fos can be metabolized to form diethylphos-
phate (DEP) and 3,5,6-trichloro-2-pyridinol
(TCPY). If the pesticide is not converted to
its oxon form, it can undergo a hydrolysis to
its organic group metabolite and dialkyl-
thionate metabolites. For chlorpyrifos, these
metabolites are diethylthiophosphate (DETP)
and TCPY (Nolan et al. 1984). These
metabolites or their glucuronide or sulfate
conjugates are excreted in urine.
Some OP pesticides are metabolized dif-
ferently than by the methods noted above.
Although malathion can undergo metabolism
similar to chlorpyrifos to form dimethylphos-
phate (DMP), dimethylthiophosphate
(DMTP), or dimethyldithiophosphate
(DMDTP), it likely ﬁrst undergoes a simple
or enzymatic hydrolysis of one or both of the
ethyl ester moieties on its alkyl side chain
(Bouchard et al. 2003; Krieger and Dinoff
2000). This preliminary hydrolysis of the side
chain renders metabolites [i.e., malathion
monocarboxylic acid (MMA) and malathion
dicarboxylic acid (MDA)] that are apprecia-
bly excreted in urine.
In a human pharmacokinetic study, the
chlorpyrifos doses administered either orally
or dermally resulted in the excretion of TCPY
in the urine of participants (Nolan et al.
1984). About 70% of the oral dose of chlor-
pyrifos was recovered in the urine. Only
about 3% of the dermal dose was recovered
in the urine, although likely because of poorer
absorption by the body via this route.
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BACKGROUND: Organophosphorus pesticides such as chlorpyrifos and malathion are widely used
insecticides. They do not bioaccumulate appreciably in humans and are rapidly metabolized and
excreted in the urine. In nonoccupational settings, exposures to these pesticides are typically spo-
radic and short-lived because the pesticides tend to degrade in the environment over time; however,
dietary exposures may be more chronic. Biologic monitoring has been widely used to assess expo-
sures, susceptibility, and effects of chlorpyrifos and malathion; thus, the information base on these
compounds is data rich. For biomonitoring of exposure, chlorpyrifos and malathion have been mea-
sured in blood, but most typically their urinary metabolites have been measured. For assessing early
effects and susceptibility, cholinesterase and microsomal esterase activities, respectively, have been
measured.
OBJECTIVES: Although many biologic monitoring data have been generated and published on these
chemicals, their interpretation is not straightforward. For example, exposure to environmental
degradates of chlorpyrifos and malathion may potentially increase f urinary metabolite levels, thus
leading to overestimation of exposure. Also, the temporal nature of the exposures makes the evalua-
tion of both exposure and effects difﬁcult. We present an overview of the current biomonitoring
and other relevant data available on exposure to chlorpyrifos and malathion and the use of these
data in various environmental public health applications. 
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Figure 1. The structures of chlorpyrifos and
malathion.Another report states that about 93% of the
chlorpyrifos oral dose is recovered as urinary
DAP metabolites, whereas about 1% of the
dermal dose was found in urine (Grifﬁn et al.
1999). In an oral dosing study of rats, chlor-
pyrifos did not accumulate in tissues other
than fat (Bakke and Price 1976).
The half-lives of chlorpyrifos in blood
(Nolan et al. 1984), adipose tissue (Kamrin
1997), and its metabolites in urine are 24 hr,
62 hr, and 15–30 hr (Griffin et al. 1999;
Kamrin 1997; Nolan et al. 1984), respectively
(Table 1).
In human volunteers, an average of about
35% of the oral dose of malathion was excreted
as the MMA metabolite, whereas MDA repre-
sented only about 8% of the total dose and the
DAP metabolites represented about 20% of
the dose (Bouchard et al. 2003). Another study
reported that oral malathion doses were recov-
ered in urine as MMA and MDA in approxi-
mately equal proportions (34–39%) and that
DMTP was the predominant DAP metabolite
(22–65%) (Krieger and Dinoff 2000). In a
forensic study evaluating the distribution of
malathion among tissues, unmetabolized
malathion was detected in the blood and urine
of all cases, with the blood level typically
higher than that of urine by a factor of 2–3
(Jadhav et al. 1992). Further, malathion was
detected in all tissues autopsied, including the
liver, spleen, kidney, lung, brain, and muscle,
with the highest concentrations in the kidney
(Jadhav et al. 1992). The doses in the autop-
sied cases were much higher than a typical
exposure; thus, whether malathion would dis-
tribute among these tissues after a low-level
exposure is uncertain.
The half-lives of malathion metabolites in
urine after dermal, oral, and intravenous
administration were 11.8, 3.2, and 4, respec-
tively (Bouchard et al. 2003; Kamrin 1997).
Further, the half-life of malathion in blood
was estimated to be about 12 min (Bouchard
et al. 2003) (Table 1).
Toxicity Data
The acute toxic effects of OP pesticides result
from their ability to inhibit the action of
acetylcholinesterase (AChE) in the nervous sys-
tem, causing a buildup of acetylcholine that
results in overstimulation of the nervous sys-
tem (Karalliedde et al. 2001). These effects are
well documented and well understood (Kwong
2002). Because OP pesticides are powerful
inhibitors of carboxylic ester hydrolases,
including AChE and butyrylcholinesterase,
people exposed to high levels of OP pesticides
can develop acute cholinergic syndrome, char-
acterized by a variety of symptoms including
rhinorrhea, salivation, lacrimation, tachycardia,
headache, convulsions, and death (Karalliedde
et al. 2001). In addition, these individuals can
also develop a proximal and reversible paralysis
called intermediate syndrome, organophos-
phate-induced delayed polyneuropathy, or
long-term neurologic sequelae. Symptoms of
repeated low-dose exposures in pesticide work-
ers and applicators include impaired memory
and concentration, disorientation, severe
depression, irritability, confusion, headache,
speech difficulties, delayed reaction times,
nightmares, sleepwalking, drowsiness, insom-
nia, and ﬂulike conditions.
Chlorpyrifos is considered moderately
toxic and is an EPA class II toxicant [i.e., oral
dose that is lethal for 50% of test animals
(LD50), 50–500 mg/kg] (Kamrin 1997;
Barr and Angerer
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Table 1. What information do we currently have for biomonitoring of exposure to a given OP pesticide?
Data Chlorpyrifos Malathion
Biomarkers of exposure TCPY, DEP, DETP, chlorpyrifos oxon MMA, MDA, DMP, DMTP, DMDTP, malathion
Biomarkers of effect AChE depression AChE depression
Biomarkers of susceptibility PON genotype/phenotype PON genotype/phenotype
Matrices used Urine, blood (serum, plasma, whole) Urine, blood (serum, plasma, whole)
Pharmacokinetics (human) Well deﬁned Well deﬁned
Interindividual variation in pharmacokinetics Not well understood Not well understood
Temporality of marker Short-lived: blood half-life, 6 hr; urine half-life, 15–24 hr Short-lived: blood half-life, 12 min; urine half-life, 3–12 hr
Temporality of exposure Potential chronic low level in diet; episodic low-level Potential chronic low level in diet; episodic low-level acute
acute exposures exposures
Speciﬁcity of biomarker See Table 2 See Table 3
Stability of the marker See Table 2 See Table 3
Primary route of environmental exposure Diet Diet
Mass balance (has anyone attempted to balance  For TCPY environmental exposures, mass balance has For MMA and MDA occupational exposures, mass balance 
deterministic measures with biomarker measures?) not been achieved achieved
Biologically active agent Chlorpyrifos oxon Malathion oxon
Known animal toxicity (acute) Oral LD50, 8–2,000 mg/kg; percutaneous LD50, 2,000  Oral LD50, 167–3,320 µg/kg/day; percutaneous LD50, 4,100 
mg/kg or greater; inhalation LD50, > 0.2 mg/L for 4–6 hr mg/kg; increased pup mortality at 200 mg/kg/day 
Known animal toxicity (chronic) 3 mg/kg/day for 2 years for increased liver weight Not known
Known human toxicity (acute) Oral NOAEL, 100 µg/kg/day Oral NOAEL, 201 µg/kg/day
Known human toxicity (chronic) Oral NOAEL, 30 µg/kg/day Not known
Known mechanism of toxicity AChE inhibitors AChE inhibitors
Human health associations Acute effects (e.g., headache, dizziness, difﬁcult  Acute effects (e.g., headache, dizziness, difﬁcult breathing, 
breathing, excessive salivation, low birth weight,  excessive salivation, convulsions, death, OIDN)
low birth length, death, OIDN)
Agreement among studies Agreement with acute effects; conﬂicting outcomes  NA
with epidemiology studies that used different 
biomarker measures
Mixtures/synergism Synergism of effects on birth outcome when diazinon NA
combined with chlorpyrifos
Link between human/animal toxicity and dose? Yes Yes
Link between human/animal dose and biomarker? No No
Abbreviations: NA, not applicable; OIDN, organophosphate-induced delayed neuropathy.
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Figure 2. General metabolism and degradation of OP
pesticides, where X = S or O, R1 is typically CH3 or
CH2CH3, and R2 is an organic moiety unique to the
pesticide or pesticide pair. Additionally, side chains
(R2) with labile functional groups such as esters may
hydrolyze to form carboxylic acid metabolites.Tomlin 1997). No teratogenic, mutagenic, or
carcinogenic effects have been observed in
animal studies; however, a small increase in
offspring mortality was observed (Kamrin
1997). Chronic exposure to chlorpyrifos over
a 2-year period resulted in increased liver
weight in dogs at a dose of 3 mg/kg/day.
Chronic effects of human chlorpyrifos
exposures include many of the symptoms of
acute toxicity, including plasma and red
blood cell cholinesterase depression (Kamrin
1997). In most instances, symptoms subsided
after eliminating the exposure. However,
newer evidence suggests some persistent
neurologic effects after moderate to low-level
nonacute exposures (Kamel et al. 2005;
Kamel and Hoppin 2004; Young et al. 2005).
Exposure to chlorpyrifos in utero has been
associated with decreased birth weight and
length (Perera et al. 2003; Whyatt et al.
2004). Exposure to chlorpyrifos coupled with
decreased paraoxonase (PON) activity has
been linked to decreased head circumference
(Berkowitz et al. 2004).
Malathion is considered slightly toxic and
is an EPA class III toxicant (i.e., oral LD50
500–5,000 mg/kg) (Kamrin 1997; Tomlin
1997). No teratogenic or carcinogenic effects
have been linked to malathion exposure in
test animals; however, rats fed high doses
(240 mg/kg/day) of malathion during preg-
nancy showed an increase in pup mortality;
no effect was observed at low doses (Kamrin
1997).
The acute LD50 values vary for each pesti-
cide and for each animal model tested.
Similarly, the acute and chronic no observed-
adverse effect levels (NOAELs) for plasma
cholinesterase depression vary for each pesti-
cide. Summarized toxicity information is
shown in Table 1.
Biomarker Characterization
An evaluation for biomarkers of chlorpyrifos
and malathion is given in Tables 2 and 3.
Aside from PON activity and AChE activity,
the biomarkers of chlorpyrifos and malathion
are different from each other but, for the
most part, are not unique from other OP
insecticides. The di- and monocarboxylic acid
metabolites of malathion are unique to
malathion exposures.
Markers of exposure. Urine is the most
common matrix used for biologic monitoring
of OP insecticide exposure, primarily because
of its ease of collection and general abundance
(Barr et al. 1999). Also, the methodology for
urinary metabolite measurements is further
developed than for other matrices and thus is
more widely available.
Of the OP pesticides registered with the
U.S. EPA for use in the United States, about
75% metabolize to form from one to three of
the six DAP metabolites (Barr et al. 2004):
DMP, DMTP, DMDTP, DEP, DETP, and
diethyldithiophosphate. Pesticide-specific
information cannot be derived from the
quantitative measurement of these metabo-
lites; however, a cumulative dose measure of
OP insecticides as a class of pesticides may be
obtained. When coupled with information on
the known use of certain pesticides such as
malathion or chlorpyrifos, the parent OP
insecticide to which one was exposed may be
inferred. However, total toxicity cannot be
derived from these measurements because
each metabolite has multiple pesticide
sources, each with different toxicities.
The pesticide-speciﬁc metabolites are also
measured in urine (Barr and Needham 2002;
Koch and Angerer 2001). The quantitative
measurement of these metabolites provides a
measure of dose for a specific pesticide. For
example, the measurement of TCPY provides
dose information specific to chlorpyrifos or
chlorpyrifos methyl. Because the metabolites
represent each half of the chlorpyrifos mol-
ecule, TCPY and the DAP metabolites of
chlorpyrifos are produced in approximately
an equimolar ratio. The TCPY and DAP
measurements should not be summed to
assess chlorpyrifos exposure because the expo-
sure would be overestimated by a factor of 2.
However, malathion is unique in that it forms
metabolites that do not represent both halves
of the molecule. Thus, malathion’s metabo-
lites can be summed as their molar equiva-
lents to evaluate total malathion exposure, if
the presence of DAPs in the urine is reason-
ably certain to be attributable to malathion
exposure (e.g., for malathion applicators)
(Krieger and Dinoff 2000).
Urinary measurements have several limi-
tations. Temporal variability of measurements
in spot urine samples has been documented
(MacIntosh et al. 1999) in some studies but
has been shown to be more stable in other
studies (Meeker et al. 2005). In addition
some researchers report more stable or repre-
sentative measurements are obtained from
ﬁrst morning void collections rather than spot
samples collected at other times of the day
(Kissel et al. 2005). Thus, in smaller studies
or in longitudinal studies, the temporal vari-
ability of measurements should be considered.
In larger cross-sectional studies, however, a
large number of samples may minimize the
overall variability of the population providing
more representative data.
Monitoring OP pesticide concentrations
in blood or blood products offers several
advantages (Barr et al. 1999). The parent
compounds, instead of their metabolites,
which are usually measured in urine, can be
directly monitored in blood. This information
is especially beneﬁcial because not all OP pes-
ticides are equally toxic. Blood measurements
provide an estimation of the dose available for
Chlorpyrifos and malathion case study
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Table 2. Evaluation of biomarkers for chlorpyrifos.
Validation parameter CP CPO TCPY DEP DETP AChE PON
Speciﬁcity of marker for exposurea 112333 N A
Matrix for measurement Bl Bl U U U Bl Bl
Alternative exposures that may  None A A, B,  A, B, D A, B, D A, C, D, E,  NA
result in presence of biomarker  chlorpyrifos nerve agents
in matrix methyl
Speciﬁcity of marker for predicting 2 2 3 3 3 1 2
health outcomea
Stability of markerb 2211111
Data from multiple labs No No Yes Yes Yes Yes Yes
Interlaboratory comparisons No No Yes Yes Yes For some No
Abbreviations: A, environmental oxon; B, environmental degradates; Bl, blood; C, O,O-dimethyl–substituted OP pesticides; CP,
chlorpyrifos; CPO, chlorpyrifos oxon; D, O,O-diethyl–substituted pesticides; E, other OP and carbamate pesticides; NA, not
applicable; U, urine; . 
a1, Most speciﬁc; 2, relatively speciﬁc with some limitations; 3, nonspeciﬁc. b1, Very stable; 2, unstable.
Table 3. Evaluation of malathion biomarkers.
Validation parameter MTN MTNO MMA MDA DMP DMTP DMDTP AChE PON
Speciﬁcity of marker for exposurea 1122333 3 N A
Matrix for measurement Bl Bl U U U U U Bl Bl
Alternative exposures that may  None A A, B A, B A, B, C A, B, C A, B, C A, C, D, E, NA
result in presence of biomarker nerve agents
in matrix
Speciﬁcity of marker for predicting 2 2 3 3 3 3 3 1 2
health outcomea
Stability of markerb 2211111 11
Data from multiple labs No No Yes Yes Yes Yes Yes Yes Yes
Interlaboratory comparisons No No Yes Yes Yes Yes Yes For some No
Abbreviations: A, environmental oxon; B, environmental degradates; Bl, blood; C, O,O-dimethyl–substituted OP pesticides;
D, O,O-diethyl–substituted pesticides; E, other OP and carbamate pesticides; MTN, malathion; MTNO, malathion oxon;
NA, not applicable; U, urine. 
a1, Most speciﬁc; 2, relatively speciﬁc with some limitations; 3, nonspeciﬁc. b1, Very stable; 2, unstable.the target site, allowing for prediction of
dose–response relationships.
The major disadvantages related to blood
measurements are the venipuncture and asso-
ciated risks (e.g., bruising, discomfort)
required to obtain the sample and the analyti-
cal challenge of measuring low toxicant con-
centrations. If available, umbilical cord blood
can overcome some of these concerns for
measuring recent in utero exposures because
venipuncture is not needed and relatively
large quantities of blood (> 30 mL) can be
collected. The invasive nature of venipuncture
puts some limits on researchers’ ability to
obtain samples from children and pregnant
women or to get high participation rates in
large-scale studies. In addition, the amount of
blood available to perform the analysis is
often limited; therefore, ultrasensitive analyti-
cal techniques may be required. Analysis is
further complicated by the inherently low
concentrations of OP pesticides present in the
blood (typically seen in the nanogram per
liter or parts per trillion range) compared with
urinary metabolite concentrations (typically
seen in the microgram per liter or parts per
billion range) (Barr et al. 1999, 2002).
Markers of effect. Cholinesterase monitor-
ing has the advantage of providing a measure
of physiologic response, but it is a less sensitive
marker of exposure (He 1999). In addition,
internal interperson variation and variation
due to exogenous factors such as pregnancy,
disease, co-exposures, and illegal drug use,
make interpretation of cholinesterase depres-
sion results difficult (Bissbort et al. 2001;
Lessenger and Reese 1999).
AChE measurements have been used
extensively in occupational monitoring of
pesticide applicators (Magnotti et al. 1988)
but have not been widely used in general
population exposure studies, primarily
because of their insensitivity to lower level
exposures.
Methodology
Urine analytic methods. Many methods have
been reported in the literature for the meas-
urement of TCPY, MMA, MDA, and the
nonspecific DAP metabolites. Methods for
measuring the six nonspecific DAP metabo-
lites are the most common (Aprea et al. 1996;
Barr and Needham 2002; Bradway and
Shaﬁk 1977; Bravo et al. 2002, 2004; Hardt
and Angerer 2000; Hernandez et al. 2002;
Moate et al. 1999; Shaﬁk et al. 1973). These
methods use liquid–liquid extraction with
polar solvents such as ethyl acetate or diethyl
ether, cyclohexyl solid-phase extraction,
azeotropic distillation, or lyophilization to
isolate the DAPs from the urine matrix.
Methods using a variety of reagents, most
often pentafluorobenzyl bromide (PFBBr),
derivatize the DAPs. Those methods that
derivatize using methylating agents such as
diazomethane cannot obtain an accurate
analysis of DMP because endogenous inor-
ganic phosphate produces the same trimethyl
derivative. The derivatized extracts are ana-
lyzed using gas chromatography (GC) cou-
pled with ﬂame photometric detection (Aprea
et al. 1996; Moate et al. 1999), ﬂame ioniza-
tion detection, mass spectrometry (MS)
(Hardt and Angerer 2000), or tandem mass
spectrometry (MS/MS) (Bravo et al. 2002,
2004; Hernandez et al. 2002). Many of these
methods have limits of detection (LODs) in
the mid-microgram per liter (ppb) range, but
several can detect levels in the low microgram
per liter range (Aprea et al. 1996; Hardt and
Angerer 2000; Moate et al. 1999) or sub-
microgram per liter range (Bravo et al. 2002,
2004). Additionally, a high-performance liq-
uid chromatography (HPLC)–MS/MS-based
method using online solid-phase extraction
has been reported, although the LODs are
higher than achievable using the more tradi-
tional methods (Hernandez et al. 2002).
Methods that measure TCPY usually
include an acid or enzyme hydrolysis followed
by solid-phase or a liquid–liquid extraction
(Barr et al. 1999). The extracted analytes are
then derivatized, with the most popular deriva-
tizing agents being PFBBr and diazomethane.
The derivatized analytes are analyzed using
GC–electron capture detection, GC-MS
(Koch and Angerer 2001), and GC-MS/MS
(Hill et al. 1995). Alternatively, the underiva-
tized TCPY can be analyzed using HPLC,
HPLC–electrospray ionization–MS/MS
(Olsson et al. 2003), or HPLC–atmospheric
pressure chemical ionization–MS/MS (Olsson
et al. 2004). The LODs of these methods vary,
but many are suitable for measuring TCPY
resulting from incidental exposures.
MMA and MDA are either measured as
the intact metabolite using HPLC-MS/MS
(Baker et al. 2000; Beeson et al. 1999; Olsson
et al. 2004) or subjected to a base hydrolysis
to form DMP and DMTP. The DMP and
DMTP can then be analyzed using the DAP
methodology (Bradway and Shafik 1977;
Fenske and Lefﬁngwell 1989). The LODs of
these methods vary, but many are suitable for
measuring metabolites resulting from inciden-
tal exposures.
Blood analytic methods. Biomarkers of
exposure. Several laboratory methods have
been reported that measure intact OP pesti-
cides in blood (Fournier et al. 1978; Frenzel
et al. 2000; Kawasaki et al. 1992; Liu et al.
1989). These methods employ a range of ana-
lytical techniques that directly affect both the
sensitivity and selectivity of the analysis.
Generally, MS-based techniques are able to
measure lower levels of the insecticides and are
more selective in their measurements (e.g.,
reduce false positives, eliminate interfering
components). The vast majority of these meth-
ods were developed for forensic applications or
for diagnosis of acute pesticide intoxication
and have LODs in the microgram per liter to
milligram per liter range—levels unsuitable for
detection of incidental exposures. For example,
Frenzel et al. (2000) reported a method to
measure methamidaphos and methyl parathion
in blood with LODs of about 25 µg/L.
However, data reported by Whyatt et al.
(2003) from their northern Manhattan/
Harlem minority birth cohort indicate that OP
insecticide levels in pregnant women and cord
blood were about three orders of magnitude
lower. Recent advances in analytical instru-
mentation have facilitated the development of
highly sensitive methods (Barr et al. 2002);
however, these methods are often complicated
and costly, potentially precluding their use for
routine analysis.
Biomarkers of effect. The electrometric
and colorimetric methods, which measure
change in pH and light absorbance, respec-
tively, most often measure AChE suppression.
Both methods measure serum and erythrocyte
cholinesterases and are relatively simple, inex-
pensive, and reproducible (Vandekar 1980).
Even with modern testing kits and methods,
the determination of serum and erythrocyte
AChE activity levels is highly dependent on
technician experience and skill.
Uncertainties in measurements. Aside from
the obvious limitations involved in the mea-
surement process (e.g., laboratory imprecision,
contamination), other forms of uncertainties in
the biomonitoring data should be considered.
Selectivity can refer to the ability of a
measurement technique to differentiate a sin-
gle analyte that is measured from other com-
ponents of the matrix (i.e., reducing false
positives). Or, selectivity can refer to the abil-
ity of the analyte measured to accurately and
unequivocally identify exposure to the target
chemical of interest. The former can be easily
achieved by the judicious use of chromatogra-
phy to resolve the analytes in time and by the
use of a selective detection technique such as
MS, electron capture detection, or nitrogen
phosphorus detection. Generally, MS-based
methods are regarded as the most selective
measurement techniques currently available;
however, these techniques are often complex
and costly and require specialized training for
operation (Barr and Needham 2002).
Furthermore, the cost of the instrumentation
often precludes their use by many laborato-
ries, thus hindering methodology transfer and
laboratory capacity building. Nonetheless, the
data generated using these methods are typi-
cally less prone to false-positive analyses (Barr
et al. 1999). Alternative methods such as
immunoassays (MacKenzie et al. 2000;
Shackelford et al. 1999) and less specialized
technologies may be employed to reduce costs
Barr and Angerer
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tive methods are used, a harmonization of the
various methods should be performed, as dis-
cussed above, to ensure that data generated
using different methods are comparable.
The selectivity of the analyte measured to
accurately reﬂect the exposure of interest does
not depend on the measurement technique
but rather on the biomarker that is measured.
Chlorpyrifos can best illustrate this point.
Chlorpyrifos can be metabolized to DEP and
DETP, which are also common to many
O,O-diethyl–substituted OP pesticides such as
diazinon. Further complicating the issue, the
DAPs may be present in environmental media
as the environmental degradates of the pesti-
cides. Thus, if DEP and DETP are detected in
the urine sample, one could conclude only
that exposure to an O,O-diethyl–substituted
pesticide or its environmental degradate has
occurred. However, additional data such as
nearby pesticide application, or prevalence of
pesticide use, could be used to help deduce
that an exposure to chlorpyrifos has occurred.
Nonetheless, the measurements indicate
unequivocally only that an exposure to the
O,O-diethyl OP pesticides or their degradates
has occurred.
The organic metabolites of chlorpyrifos
are TCPY and its conjugates. These metabo-
lites are also common to chlorpyrifos methyl.
Additionally, TCPY can be derived from
exposure to its environmental degradates: the
oxons of either chlorpyrifos or chlorpyrifos
methyl and TCPY itself. Thus, urinary TCPY
can indicate exposure to several different
chemicals, including environmental TCPY;
therefore, it may not be an appropriate bio-
marker for low-level exposures to chlorpyrifos,
especially when TCPY dominates the environ-
mental media (Morgan et al. 2004).
The only way to unequivocally identify
chlorpyrifos exposure is by measuring the
intact pesticide in blood samples because the
intact pesticide is not appreciable in urine.
However, blood measurements are inherently
difﬁcult because the levels are typically about
three orders of magnitude lower than urinary
metabolite measurements; thus, highly sensi-
tive analytical techniques must be used, which
in turn generally drive up the cost of analysis.
These techniques are not available for many
of the OP insecticides; thus, total class expo-
sure information would be difﬁcult to obtain.
Furthermore, OP pesticides are less stable in
blood than their metabolites are in urine;
therefore, special precaution to prevent degra-
dation must be used.
Temporal variability in spot urine sam-
ples. The variability of OP insecticide
metabolite concentrations in samples col-
lected from an individual over time is of con-
cern. If a single sample taken at a given point
in time cannot accurately assess a person’s
average exposure over a given time frame,
then multiple samplings are necessary,
although this can become costly and burden-
some to the participant. Temporal variability
can include the variation of a given chemical
in multiple samples collected on a single day
or can include variation among days, months,
or seasons. How accurately can a single sam-
ple represent a day’s exposure to a given
chemical, or how accurately can a single sam-
ple represent a person’s exposure over a longer
period of time? These questions can be more
easily answered for chronic exposures because
the exposure is repeated; thus, the amount in
a given sample would likely be representative
of that average exposure. However, for
episodic exposures, which is likely the case
with OP insecticide exposures, the questions
become more difficult to answer and may
vary from pesticide to pesticide. For urine
matrix a 24-hr urine sample is preferred,
rather than a single spot sample on a given
day; however, this is very burdensome for the
participant and is often logistically difﬁcult. If
a 24-hr sample cannot be obtained, a first-
morning void is often preferred because the
urine is more concentrated and the collection
represents a longer window of accumulation
(usually > 8 hr); thus, the analyte level is more
likely to reflect an average daily concentra-
tion. Regardless of whether the sample col-
lected is a first morning void, if the sample
does not represent a full 24-hr collection, the
variability in urine concentrations (i.e., degree
of dilution of the urine components as a
result of water intake) must be considered.
To evaluate daily, monthly, or seasonal
variations of analyte in urine, sequential sam-
ples are often taken days or weeks apart to
evaluate the intraindividual variation over
time and to determine whether an accurate
classification of exposure is possible from a
single spot sample. Several studies have evalu-
ated the weekly or seasonal variation for cer-
tain pesticide metabolites in urine, although
most pesticide metabolites have not been stud-
ied. The existing data indicate that a single
sample is usually not sufficient to accurately
quantify exposure to the target pesticide; thus,
multiple samples must be collected over time
(MacIntosh et al. 1999). Newer data, how-
ever, suggest a single sample may allow a
broad classiﬁcation of exposure (Meeker et al.
2005). Further studies to indicate the variabil-
ity of commonly measured analytes in urine
should be conducted to ensure that multiple
samples are required for the target analyte(s),
thus reducing cost, and to better establish the
most appropriate sampling time frame (e.g.,
collect samples every fourth day). In all likeli-
hood, sampling for nonpersistent chemicals
will require multiple samples taken over the
course of the study at regular intervals (e.g.,
weekly, monthly, semiannually).
Exposure Assessment
Exposure assessments for OP pesticides have
used historical or observational measurements,
multimedia environmental measurements, and
biomonitoring measurements. In addition,
models have been developed to predict OP
pesticide exposures. The models rely primarily
on an understanding of product use, measure-
ments of OP pesticides in various media, esti-
mates of human contact, and pharmacokinetic
assumptions based on animal and human
data. The model estimates have typically been
validated using experimental data from bio-
monitoring. Experimental data using ques-
tionnaires or environmental, personal, and
biologic monitoring have provided a wealth of
exposure assessment data, although with some
limitations.
Historical or observational measurements.
Four types of historical or observational instru-
ments are used to collect data on chlorpyrifos
or malathion exposure: a) questionnaires
including product use information, b) time
and activity logs, c) diaries of speciﬁc activities
such as foods eaten, and d) visual assessments,
database inventories, and check lists. Although
data collected from these instruments have not
always been reliably linked with biomonitoring
data, they have been used frequently, in con-
junction with biomonitoring data, to evaluate
predictors of exposure.
Multimedia environmental measurements.
Biomonitoring measurements are limited in
that they provide little if any information on
the route or pathway of exposure; however, in
many instances, this is seen as an advantage
because all routes or pathways are integrated
so that only one exposure measure is needed.
Further, typical biomonitoring measurements
from single spot samples provide no informa-
tion on the frequency, magnitude, and dura-
tion of exposures. Thus, many studies have
evaluated chlorpyrifos or malathion exposure
using measurements in multiple environmen-
tal and personal matrices such as air, water,
duplicate diet, and dust. A single measure-
ment in these matrices, as with biomonitoring
measurements, provides a snapshot estimate of
the exposure as the chlorpyrifos or malathion
levels may change in the matrices over time.
The measurements, when coupled with histor-
ical and observational data, may allow the cal-
culation of the frequency, magnitude, and
duration of exposures. In addition, these mea-
surements can be used as an input into deter-
ministic models to estimate total exposure.
Increasingly, environmental measurements
used in exposure assessment are also aug-
mented with biomonitoring measurements.
Biologic measurements. Blood measure-
ments. Few studies have focused on biomoni-
toring measurements of chlorpyrifos or
malathion in blood primarily because of the
limitations of blood as a matrix as outlined
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been used to evaluate fetal exposures to chlor-
pyrifos. The plasma concentrations of chlor-
pyrifos ranged from < 1 to 10 pg/mL (Whyatt
et al. 2003, 2004). Cord and maternal plasma
chlorpyrifos levels were highly correlated
(Whyatt et al. 2003). Pooled serum samples
had a mean chlorpyrifos concentration of
9 pg/mL (Barr et al. 2002). Chlorpyrifos has
been detected at somewhat higher levels in cit-
rus farmers. In addition, malathion has been
detected in postmortem blood samples from a
fatal poisoning case at very high levels
(1.9–517 µg/mL) (Jadhav et al. 1992).
A potentially novel marker of OP insecti-
cide exposure in blood is the measurement of
biomolecular adducts of OP insecticides.
Fidder et al. (2002) reported a technique for
retrospectively detecting exposure to OP nerve
agents by measuring a specific nonapeptide
that represents the adducted portion of butryl-
cholinesterase. They demonstrated its poten-
tial applicability to OP insecticides; thus,
similar methods are being developed for OP
insecticides. These measurements offer the
advantage of a longer term dosimeter of expo-
sure using potentially an early marker of effect.
Urinary metabolite measurements. Most
biologic monitoring measurements assessing
chlorpyrifos or malathion exposure have
involved the measurement of their urinary
metabolites. The urinary metabolite levels of
various occupational and nonoccupational
studies have been previously reviewed (Barr
et al. 2004, 2005). Concentrations of the uri-
nary metabolites reported in the literature vary
greatly depending on the exposure scenario
but usually hover in the low nanograms per
milliliter range for typical background expo-
sures (Barr et al. 2004, 2005). Because urinary
TCPY can also be derived from exposure to
environmental TCPY or other sources, it may
not be a good marker of chlorpyrifos exposure
(Morgan et al. 2004). Urinary MMA and
MDA have been less frequently measured as
the direct metabolites. Of these, MDA has
been measured the most often because of its
greater analytical stability compared to MMA.
Environmental Public Health
Uses of Chlorpyrifos and
Malathion Biomonitoring Data
Identification of prevalent exposures. To
evaluate the prevalence of exposure to either
chlorpyrifos or malathion, existing biomoni-
toring data must be coupled with information
about the relative contribution of environ-
mental degradates to the overall urinary
metabolite levels. To properly evaluate the
prevalence of exposures, we must have a better
understanding of the environmental degradate
contribution from the various exposure matri-
ces and that pathway(s) of exposure predomi-
nates. Further, a more complete picture of OP
insecticide exposure could be obtained if pesti-
cide-speciﬁc biomonitoring data were available
for more OP insecticides. Regardless, the exist-
ing data can provide a reasonable upper-
bound estimate of the prevalence of exposures
to chlorpyrifos and malathion.
Evaluation of trends in exposure.
Assuming that environmental degradate con-
tributions to urinary levels remain relatively
constant over time that may or may not be
the case, urinary measurements taken over
time should prove suitable for evaluating tem-
poral trends in exposure. Biomarker levels
would represent a maximum exposure level.
Signiﬁcant decreases in these levels over time
would suggest that exposures to the parent
chemical and/or degradates or even the use of
these pesticides were reduced. For chlorpyri-
fos evaluation, one should recognize that a
percentage of the TCPY may be also from
exposure to chlorpyrifos methyl; thus, if the
relative use of these two pesticides remains
constant, temporal trend evaluations should
be valid. However, if the use patterns are
moving in opposite directions (i.e., chlorpyri-
fos use is decreasing, but chlorpyrifos methyl
use is increasing), true trends in exposure to
one of the chemicals may be masked. A par-
ticular advantage of the large population-
based studies such as the National Health and
Nutrition Examination Survey (NHANES) is
that the sample size is sufﬁcient and the par-
ticipant selection is completely random such
that the “noise” in the data set due to unusual
exposures not typical of the general popula-
tion should be minimized. Blood chlorpyrifos
measurements alone should be suitable for
evaluation of temporal trends in chlorpyrifos
exposures if background levels are measurable
with existing methodology.
Identiﬁcation of unusually exposed popu-
lation subgroups. The existing biomonitoring
data are sufficient to evaluate unusually
exposed population subgroups as long as the
subgroups have been defined at the study
level and the relative contribution to the
measurements from exposure to the environ-
mental degradates is known. For example, the
NHANES database is sufficient to identify
the most highly exposed demographic groups
deﬁned in the study; however, certain demo-
graphic information such as geographic sub-
groups or infants are not a part of the study
or are not a deﬁned variable for analysis. To
augment these data, targeted studies looking
at similar exposures in these populations of
interest should be conducted. Alternatively,
the NHANES study could be expanded to
include these additional population groups,
although this may not be logistically feasible.
Provide reference range data for compari-
son. The existing population data provide ade-
quate information from which reference range
concentrations can be derived. To supplement
these data, exposure assessment or health
effects studies can also enroll control subjects
to provide reference data for their specific
geographic region.
Evaluation of effectiveness of an interven-
tion or regulatory action. Assuming that envi-
ronmental degradate contributions to urinary
levels remain relatively constant over time
(e.g., 80% of TCPY from dietary exposure is
from environmental TCPY), urinary meas-
urements taken over time should prove suit-
able for evaluating the effectiveness of
regulations, providing “background” or pre-
regulatory levels were determined. Blood
measurements should be suitable on their
own to evaluate the effectiveness of regulatory
actions on reducing exposures.
Risk assessment. Urinary biomonitoring
measurements have been used in risk assess-
ment approaches for both chlorpyrifos and
malathion; however, these data alone are not
sufficient for risk assessment. Data on the
magnitude, duration, and frequency of expo-
sures should be obtained, likely through envi-
ronmental measurements. In addition,
detailed human pharmacokinetic information
is required to appropriately evaluate the vari-
ous biologic compartments into which the
chemicals will be deposited or eliminated.
Animal and in vitro toxicity (or other health
end point) information should be used in
conjunction with the human exposure data to
perform the risk assessment.
Conclusions
Biomonitoring of exposure to OP insecticides,
primarily for chlorpyrifos and malathion, has
been performed extensively over the last
30 years, providing a wealth of data for evalua-
tion. However, these data should be used cau-
tiously for each intended application, and the
uncertainties associated with the measures
should be acknowledged. Larger gaps in data
required to use biomonitoring data for a given
purpose may produce more uncertainties in the
interpretation; however, biomonitoring data
alone can serve a better purpose than making
public health decisions without any human
data. Although much data exist, we can recom-
mend several research activities that would
enhance the utility of the existing database and
reduce the uncertainties associated with its use:
• Perform additional multimedia exposure
assessments to better deﬁne relative contribu-
tion of environmental degradates to urinary
metabolite concentrations (e.g., preformed
DAPs or TCPY in the environment). Include
additional OP insecticides in the assessments
to address combined toxicity issues.
• Develop methods to measure all urinary
pesticide-speciﬁc metabolites of OP insecti-
cides used in the United States to allow dif-
ferentiation of effects specifically due to
chlorpyrifos or malathion exposures.
Barr and Angerer
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• Develop methods to provide blood pesticide
measurements for all OP insecticides used
in the United States to allow differentiation
of effects speciﬁcally due to chlorpyrifos or
malathion exposures.
• Develop methods to evaluate biomolecular
adducts of OP insecticides to provide a
longer term dosimeter of exposure.
• Perform exposure assessment studies look-
ing at targeted populations of interest such
as children, general population of defined
geographic regions, and pregnant women.
• Perform chronic health effects studies in
animals at doses similar to those encoun-
tered in human exposure scenarios.
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